These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 13952223)

  • 21. [ACTION OF MONOAMINE OXIDASE INHIBITORS ON GASTRIC SECRETION STIMULATED BY RESERPINE IN MAN].
    LAMBERT R; MARTIN F; HALLACQ A
    C R Seances Soc Biol Fil; 1963 Aug; 157():826-30. PubMed ID: 14081741
    [No Abstract]   [Full Text] [Related]  

  • 22. ON THE GANGLIONIC ACTIONS OF CERTAIN ANTI-DEPRESSANT DRUGS.
    URQUIAGA X; VILLARREAL J; ALONSO-DEFLORIDA F; PARDO EG
    Arch Int Pharmacodyn Ther; 1963 Nov; 146():126-33. PubMed ID: 14077702
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the relationship of 5-hydroxytryptamine and the enterochromaffin cell to anaphylactic shock in mice.
    GERSHON MD; ROSS LL
    J Exp Med; 1962 Feb; 115(2):367-82. PubMed ID: 13898067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [THE ROLE OF CATECHOLAMINES IN THE CONTROL OF HYPOTHALAMIC NEUROSECRETION. EFFECTS OF RESERPINE COMPOUNDS, MONOAMINE OXIDASE INHIBITORS AND D-1 DOPA 5-HTP DECARBOXYLASE INHIBITORS].
    CAHN J; HEROLD M
    Agressologie; 1964; 5():451-63. PubMed ID: 14192331
    [No Abstract]   [Full Text] [Related]  

  • 25. THE INFLUENCE OF DRUG-TISSUE INTERACTIONS ON THE INHIBITION OF MONOAMINE OXIDASE BY PHENIPRAZINE AND IPRONIAZID.
    HORITA A
    J Pharmacol Exp Ther; 1963 Nov; 142():141-6. PubMed ID: 14085495
    [No Abstract]   [Full Text] [Related]  

  • 26. [INHIBITION OF RAT BRAIN MONOAMINE OXIDASES BY BETA-PHENYLISOPROPYLHYDRAZINE AND HARMALINE: HISTOCHEMICAL STUDY OF THE ACTION OF THESE INHIBITORS AND THEIR ANTAGONISM].
    BOUCHAUD C; COUTEAUX R; GAUTRON J
    C R Hebd Seances Acad Sci; 1965 Jan; 260():348-51. PubMed ID: 14305447
    [No Abstract]   [Full Text] [Related]  

  • 27. Facilitation of metrazol-in-duced seizures by iproniazid and betaphenylisopropylhy-drazine in mice.
    SPOERLEIN MT; ELLMAN AM
    Arch Int Pharmacodyn Ther; 1961; 133():193-9. PubMed ID: 13915887
    [No Abstract]   [Full Text] [Related]  

  • 28. The depletion of catecholamine of the rabbit's atria by reserpine in vitro.
    MATSUO T
    Jpn J Pharmacol; 1962 Jun; 12():62-71. PubMed ID: 13933794
    [No Abstract]   [Full Text] [Related]  

  • 29. The pressor effect of reserpine after monoamine-oxidase inhibitors.
    GARATTINI S; FRESIA P; MORTARI A; PALMA V
    Med Exp Int J Exp Med; 1960; 2():252-9. PubMed ID: 13703426
    [No Abstract]   [Full Text] [Related]  

  • 30. [Action of reserpine and iproniazid on Caratuis auratus L. activity].
    Deliège M
    C R Seances Soc Biol Fil; 1969 Apr; 162(10):1865-7. PubMed ID: 4238670
    [No Abstract]   [Full Text] [Related]  

  • 31. Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835).
    SPECTOR S; SHORE PA; BRODIE BB
    J Pharmacol Exp Ther; 1960 Jan; 128():15-21. PubMed ID: 13833205
    [No Abstract]   [Full Text] [Related]  

  • 32. [THE ROLE OF CATECHOLAMINES IN THE CONTROL OF HYPOTHALAMIC NEUROSECRETION. EFFECTS OF RESERPINE, A MONOAMINE OXIDASE INHIBITOR AND DIFFERENT D-1 DOPA 5-HTP DECARBOXYLASE INHIBITORS].
    SOULAIRAC A; SOULAIRAC ML
    Agressologie; 1964; 5():465-71. PubMed ID: 14192332
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of 2 monoamine oxidase inhibitors (iproniazid and JB 516) in the therapy of arterial hypertension.
    ORVIS HH; TAMAGNA IG; THOMAS RE
    Am J Med Sci; 1959 Sep; 238():336-43. PubMed ID: 14429171
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of antidepressive substances on monoamine oxidase in vitro and in vivo].
    VITEK V; RYSANEK K
    Cesk Farm; 1962 Oct; 11():399-404. PubMed ID: 13997520
    [No Abstract]   [Full Text] [Related]  

  • 35. CLINICAL EXPERIENCE WITH THE MONOAMINE OXIDASE INHIBITOR, DL-SERINE-N-ISOPROPYLHYDRAZIDE (RO 4-1038), IN THE TREATMENT OF HYPERTENSION.
    MAXWELL MH; ROTH SI; GONICK HC; KLEEMAN CR
    Am Heart J; 1963 Aug; 66():151-63. PubMed ID: 14051181
    [No Abstract]   [Full Text] [Related]  

  • 36. THE PHARMACOLOGY OF 3-PHENOXYPROPYLGUANIDINE.
    CHEN G; ENSOR CR; MCCARTHY DA; MCLEAN JR; CAMPBELL A
    J Pharmacol Exp Ther; 1964 Mar; 143():374-82. PubMed ID: 14161151
    [No Abstract]   [Full Text] [Related]  

  • 37. [EFFECT OF CHANGES IN MEDIATOR METABOLISM ON THE DEVELOPMENT OF HEART HYPERTROPHY].
    MEERSON FZ; ROZANOVA LS
    Biull Eksp Biol Med; 1964 Mar; 57():34-7. PubMed ID: 14185598
    [No Abstract]   [Full Text] [Related]  

  • 38. MONOAMINE OXIDASE INHIBITORS. THE SYNTHESIS AND EVALUATION OF A SERIES OF SUBSTITUTED ALKYLHYDRAZINES.
    DRAIN DJ; HOWES JG; LAZARE R; SALAMAN AM; SHADBOLT R; WILLIAMS HW
    J Med Chem; 1963 Jan; 6():63-9. PubMed ID: 14174033
    [No Abstract]   [Full Text] [Related]  

  • 39. Interactions of bretylium and other drugs on guinea-pig atria: evidence for inhibition of neuronal monoamine oxidase by bretylium.
    Furchgott RF; Garcia PS; Wakade AR; Cervoni P
    J Pharmacol Exp Ther; 1971 Nov; 179(2):171-85. PubMed ID: 4399958
    [No Abstract]   [Full Text] [Related]  

  • 40. "FALSE NEUROCHEMICAL TRANSMITTERS" AND THE MECHANISM OF SYMPATHETIC BLOCKADE BY MONOAMINE OXIDASE INHIBITORS.
    KOPIN IJ; FISCHER JE; MUSACCHIO JM; HORST WD; WEISE VK
    J Pharmacol Exp Ther; 1965 Feb; 147():186-93. PubMed ID: 14259496
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.